Literature DB >> 4353389

Enzyme activated alkylating agents.

C R Ball, J A Double, J Goodban.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4353389      PMCID: PMC2009087          DOI: 10.1038/bjc.1973.92

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  7 in total

1.  Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.

Authors:  R W Baldwin; M R Price; R A Robins
Journal:  Nat New Biol       Date:  1972-08-09

2.  Disappearance after chemotherapy of blocking serum factors as measured in vitro with lymphocytes cytotoxic to tumor cells.

Authors:  J G Sinkovics; J R Cabiness; C C Shullenberger
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

3.  Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines.

Authors:  J E Sokal; C W Aungst; T Han
Journal:  Cancer Res       Date:  1972-07       Impact factor: 12.701

4.  Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.

Authors:  G A Currie; F Lejeune; G H Fairley
Journal:  Br Med J       Date:  1971-05-08

5.  Autoimmunization with irradiated tumour cells in human malignant melanoma.

Authors:  R L Ikonopisov; M G Lewis; I D Hunter-Craig; D C Bodenham; T M Phillips; C I Cooling; J Proctor; G H Fairley; P Alexander
Journal:  Br Med J       Date:  1970-06-27

6.  Aryl-2-halogenoalkylamines. XXVI. Glucuronic, sulphuric and phosphoric esters of p-di-2-chloroethylaminophenol.

Authors:  M A Bukhari; J L Everett; W C Ross
Journal:  Biochem Pharmacol       Date:  1972-04-01       Impact factor: 5.858

7.  Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.

Authors:  G A Currie; C Basham
Journal:  Br J Cancer       Date:  1972-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.